Federal Register / Vol. 62, No. 65 / Friday, April 4, 1997 / Notices 16169

profit; Not-for-profit institutions;

Federal Government; State, Local or

Tribal Government. Type of

Respondents: Adult cancer patients;

members of the public; health care

professionals; organizational

representatives. The annual reporting

burden is as follows: Estimated Number

of Respondents: 13,780; Estimated

Number of Responses per Respondent:

1; Average Burden Hours Per Response;

1458; and Estimated Total Annual

Burden Hours Requested: 2,010. There

are no Capital Costs, Operating Costs

and/or Maintenance Costs to report.

Request for Comments

Written comments and/or suggestions

from the public and affected agencies

are invited on one or more of the

following points: (1) Whether the

proposed collection of information is

necessary for the proper performance of

the function of the agency, including

whether the information will have

practical utility; (2) The accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used; (3)

Ways to enhance the quality, utility, and

clarity of the information to be

collected; and (4) Ways to minimize the

burden of the collection of information

on those who are to respond, including

the use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

their forms of information technology.

For Further Information Contact: To

request more information on the

proposed project or to obtain a copy of

the data collection plans and

instruments, contact Ellen Eisner,

Communications Research Manager,

Health Promotion Branch, OCC, NCI,

NIH, Building 31, Room 10A03, 9000

Rockville Pike, Bethesda, MD 20892, or

call non-toll-free number (301) 496–

6667 or E-mail your request, including

your address to

EisnerE@occ.nci.nih.gov.

Comments Due Date: Comments

regarding this information collection are

best assured of having their full effect if

received by June 3, 1997.

Dated: March 27, 1997.

Nancie L. Bliss,

Project Clearance Liaison, NCI.

[FR Doc. 97–8595 Filed 4–3–97; 8:45 am]

BILLING CODE 4140–01–M

A Comprehensive Alcohol Education

Program for Pre-Adolescents Using

Interactive Multimedia; Submission for

OMB Review; Comment Request

SUMMARY: Under the provisions of

Section 3506  (2) (A) of the Paperwork

Reduction Act of 1995, the National

Institute on Alcohol Abuse and

Alcoholism (NIAAA), National

Institutes of Health (NIH) has submitted

to the Office of Management and Budget

(OMB) a request to review and approve

the information collection listed below.

This proposed information collection

was previously in the Federal Register

on March 22, 1996, and allowed 60 days

for public comment. No public

comments were received. The purpose

of this notice is to allow an additional

30 days for public comment. The NIH

may not conduct or sponsor, and the

respondent is not required to respond

to, an information collection that has

been extended, revised, or implemented

on or after September 28, 1997, unless

it displays a currently valid OMB

control number.

PROPOSED COLLECTION: Title: A

Comprehensive Alcohol Education

Program for Pre-Adolescents Using

Interactive Multimedia. Type of

Information Collection request: NEW.

Need and Use of Information Collection:

The information proposed for collection

will be used by the NIAAA to determine

the efficacy of interactive multimedia

for delaying the onset of drinking among

7th and 8th grade males and females.

Interactive multimedia enables the

combination of the elements of

television and movies that engage and

motivate the target populations with

computer-based interaction,

simulations, and games to (1) increase

information about the negative

consequences of teen drinking and (2)

teach practical skills for avoiding and

refusing alcohol. Subject participation

will involve (1) focus groups, during

development of the multimedia

program, and (2) post-development

behavioral trials.

Frequency of Response: On Occasion.

Affected Public: Pre-adolescents.

Type of Respondents: Minor Students

(Grades 7th and 8th).

Estimated Number of Respondents:

308.

Estimated Number of Responses per

Respondent: 1.

Average Burden Hours per Response:

.281.

And Estimated Total Annual Burden

Hours Requested: 89.2.

There are no Capital Costs to report.

There are no Operating or Maintenance

Costs to report.

The annual burden estimates are as

follows:

Type and number of respondents

Responses

per respondent

Total responses Hours Total hours

Focus Group Subjects 40 ................................................................................................. 1 40 0.5 20

Trial Subjects 268 ............................................................................................................. 4 1072 0.5 536

Total Number of Respondents: 308.

Total Number of Responses: 1112.

Total Hours: 556.

REQUEST FOR COMMENTS: Comments are

invited on: (a) whether the proposed

collection is necessary, including

whether the information has practical

use; (b) ways to enhance the clarity,

quality, and use of the information to be

collected; the accuracy of the agency

estimate of burden of the proposed

collection; and (d) ways to minimize the

collection burden of the respondents.

Send written comments to Dr. Kendall

Bryant, Prevention Research Branch,

Division of Clinical and Prevention

Research (DCPR), NIAAA, NIH, Willco

Building, Room 505, 6000 Executive

Boulevard, MSC 7003, Bethesda,

Maryland 20892–7003.

DIRECT COMMENTS TO OMB: Written

comments and/or suggestions regarding

the item(s) contained in this notice,

especially regarding the estimated

public burden and associated response

time should be directed to the Office of

Management and Budget, Office of

Regulatory Affairs, New Executive

Office Building, Room 10235,

Washington, DC 20503, Attention: Desk

Officer for NIH.

FOR FURTHER INFORMATION CONTACT: To

request more information on the

proposed project or to obtain a copy of

the data collection plans, contact Dr.

Kendall Bryant, Prevention Research

Branch, Division of Clinical and

Prevention Research (DCPR), NIAAA,

NIH, Willco Building, Room 505, 6000

Executive Boulevard, MSC 7003,

Bethesda, Maryland 20892–7003, or call

non-toll-free number (301) 443–8820.

COMMENTS DUE DATE: Comments

regarding this information collection are
16170 Federal Register / Vol. 62, No. 65 / Friday, April 4, 1997 / Notices

best assured of having their full effect if

received by May 5, 1997.

Dated: March 26, 1997.

Martin K. Trusty,

Executive Officer, NIAAA.

[FR Doc. 97–8594 Filed 4–3–97; 8:45 am]

BILLING CODE 4140–01–M

Consensus Development Conference

on Genetic Testing for Cystic Fibrosis

Notice is hereby given of the NIH

Consensus Development Conference on

‘‘Genetic Testing for Cystic Fibrosis,’’

which will be held April 14–16, 1997,

in the Natcher Conference Center of the

National Institutes of Health, 9000

Rockville Pike, Bethesda, Maryland

20892. The conference begins at 8:30

a.m. on April 14, at 8:30 a.m. on April

15, and at 9:00 a.m. on April 16.

At the beginning of this decade, a test

was developed which could identify

individuals who carried the genetic

mutation associated with cystic fibrosis.

Concerned that this test might be

inappropriately or prematurely used, a

number of genetic and health

professional organizations issued

recommendations on its use. These

groups considered the circumstances

under which the tests should be offered

and the populations that would

potentially benefit. In almost every case,

recommendations were made against

using the test for large-scale populationbased screening until more sensitive

tests were developed and more had been

learned about the risks and benefits of

genetic testing for individuals and their

families. Several statements called for

additional support for research on the

educational, laboratory, counseling,

ethical, and cost/benefit issues

associated with the delivery of

population-based screening for cystic

fibrosis. Since that time new research

has yielded a large body of new data on

these issues.

This conference will bring together

the research investigators, health care

providers, epidemiologists, geneticists,

ethicists and other experts, as well as

representatives of the public, to present

and discuss the latest data.

After 11⁄2 days of presentations and

audience discussion, an independent,

non-Federal consensus panel will weigh

the scientific evidence and write a draft

statement that it will present to the

audience on the third day. The

consensus statement will address the

following key questions:

—What is the current state of knowledge

regarding cystic fibrosis natural

history, epidemiology, genotypephenotype correlations, treatment,

and genetic testing in various

populations?

—What has been learned about genetic

testing for cystic fibrosis regarding

(public and health professional)

knowledge and attitudes, interest and

demand, risks and benefits,

effectiveness, cost, and impact?

—Should cystic fibrosis carrier testing

be offered to: (1) individuals with a

family history of cystic fibrosis; (2)

adults in the preconception or

prenatal period; and/or (3) the general

population?

—What are the optimal practices for

cystic fibrosis genetic testing (setting,

timing, and the practices of education,

consent, and counseling)?

—What should be the future directions

for research relevant to genetic testing

for cystic fibrosis and, more broadly,

for research and public policy on

genetic testing?

The primary sponsors of this meeting

are the National Human Genome

Research Institute and the NIH Office of

Medical Applications Research. The

conference is cosponsored by: the

National Institute of Diabetes and

Digestive and Kidney Diseases; the

National Heart, Lung, and Blood

Institute; the National Institute of Child

Health and Human Development; the

NIH Office of Rare Diseases; the

National Institute of Mental Health; the

National Institute of Nursing Research;

the NIH Office of Research on Women’s

Health; the Agency for Health Care

Policy Research; and the Centers for

Disease Control and Prevention.

Advance information on the

conference program and conference

registration materials may be obtained

from: Rose Salton, Technical Resources

International, Inc., 3202 Tower Oaks

Blvd., Suite 200, Rockville, Maryland

20852, (301) 770–3153, confdept@techres.com. The consensus statement will

be submitted for publication in

professional journals and other

publications. In addition, the statement

will be available beginning April 16,

1997 from the NIH Consensus Program

Information Center, P.O. Box 2577,

Kensington, Maryland 20891, phone 1–

888–NIH–CONSENSUS (1–888–644–

2667) and from the NIH Consensus

Program site on the World Wide Web at

http://consensus.nih.gov.

Dated: March 26, 1997.

Ruth L. Kirschstein,

Deputy Director, NIH.

[FR Doc. 97–8593 Filed 4–3–97; 8:45 am]

BILLING CODE 4140–01–M

National Center for Research

Resources; Notice of Meeting of the

National Advisory Research Resources

Council and its Planning

Subcommittee

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

National Advisory Research Resources

Council (NARRC), National Center for

Research Resources (NCRR). This

meeting will be open to the public as

indicated below. Attendance by the

public will be limited to space available.

This meeting will be closed to the

public as indicated below in accordance

with provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

and sec. 10(d) of Pub. L. 92–463, for the

review, discussion and evaluation of

individual grant applications. The

applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material, and personal information

concerning individuals associated with

the applications, the disclosure of

which would constitute a clearly

unwarranted invasion of personal

privacy.

Ms. Maureen Mylander, Public Affairs

Officer, NCRR, National Institutes of

Health, 1 Rockledge Center, Room 5146,

6705 Rockledge Drive, MSC 7965,

Bethesda, Maryland 20892–7965, (301)

435–0888, will provide a summary of

the meeting and a roster of the members

upon request. Other information

pertaining to the meeting can be

obtained from the Executive Secretary

indicated. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

contact the Executive Secretary in

advance of the meeting.

Name of Committee: The Subcommittee on

Planning of the National Advisory Research

Resources Council.

Place of Meeting: National Institutes of

Health, 9000 Rockville Pike, Conference

Room D, Natcher Building 45, Bethesda,

Maryland 20892.

Open: May 22, 7:30 a.m.–8:45 a.m.

Purpose/Agenda: To discuss policy issues.

Name of Committee: National Advisory

Research Resources Council.

Place of Meeting: National Institutes of

Health, 9000 Rockville Pike, Conference

Room E1 and E2, Natcher Building 45,

Bethesda, Maryland 20892.

Open: May 22, 9 a.m. until recess.

Closed: May 23, 8:30 a.m. until 9:45 a.m.

Open: May 23, 10:00 a.m. until

adjournment.

Purpose/Agenda: Report of Center Director

and other issues related to Council business.

Executive Secretary: Louise Ramm, Ph.D.,

Deputy Director, National Center for

Research Resources, Building 12A, Room